Calpain II activity and calpastatin content in brain regions of 3- and 24-month-old rats.
In previous studies, we found a significantly higher (100% or more) content of cathepsin D in the aging brain. In the present study, we determined activity of Ca2(+)-activated neutral protease requiring millimolar Ca2+ (calpain II, CANP II) and amount of its endogenous inhibitor, calpastatin, in extracts of various brain regions of 3-month-old and 24-month-old male Fischer-344 rats. Calpain II was separated from calpastatin in a single step (chromatography) and its activity was tested using as substrates [methyl-14C]alpha-casein, the cytoskeletal proteins desmin and actin, and a mixture of neurofilament triplet proteins and glial fibrillary acidic proteins (GFAP). We found no changes in calpain II activity in pons-medulla and spinal cord, but significant increases were detected in cortex (72%) and striatum (63%) of the 24-month-old rats using [methyl-14C]alpha-casein as substrate. The profile of desmin and actin breakdown showed regional variations somewhat different from those of [methyl-14C]alpha-casein. With desmin, the greatest increases with age were in the striatum (82%) and hypothalamus (46%), but there were no alterations in cortex, cerebellum, and pons-medulla. With actin, slightly enhanced activity in cortex and cerebellum was noticeable. Calpastatin content in brain regions was also increased, with the regional pattern of increase fairly similar to the pattern of enzyme activity increase. The causes and the physiological consequences of increased calpain and calpastatin content in the aged brain are being investigated. That changes with age are somewhat different with the various brain protein substrates indicates that some of the properties of the enzyme also undergo alteration with age.(ABSTRACT TRUNCATED AT 250 WORDS)
Kenessey
A
A
Center for Neurochemistry, Nathan S. Kline Institute for Psychiatric Research, Ward's Island, New York 10035.
Banay-Schwartz
M
M
DeGuzman
T
T
Lajtha
A
A
D000199:Actins / Q000378:metabolism; D000375:Aging / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000201:enzymology / Q000254:growth & development*; D002135:Calcium-Binding Proteins / Q000378:metabolism*; D002154:Calpain / Q000378:metabolism*; D002364:Caseins / Q000378:metabolism; D002531:Cerebellum / Q000201:enzymology / Q000254:growth & development; D002540:Cerebral Cortex / Q000201:enzymology / Q000254:growth & development; D003893:Desmin / Q000378:metabolism; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D008297:Male; D008526:Medulla Oblongata / Q000201:enzymology / Q000254:growth & development; D011149:Pons / Q000201:enzymology / Q000254:growth & development; D051381:Rats; D011916:Rats, Inbred F344; D013116:Spinal Cord / Q000201:enzymology / Q000254:growth & development
D000199:Actins; D002135:Calcium-Binding Proteins; D002364:Caseins; D003893:Desmin; D005904:Glial Fibrillary Acidic Protein; C033668:calpastatin; D002154:Calpain